v3.26.3
Segment Reporting - Schedule of Reconciliation of Adjusted EBITDA (Details) - USD ($)
$ in Millions
3 Months Ended 9 Months Ended
Sep. 30, 2026
Sep. 30, 2025
Sep. 30, 2026
Sep. 30, 2025
Segment Reporting [Abstract]        
Adjusted EBITDA $ 346.6 $ 300.1 $ 1,043.4 $ 932.3
Stock-based compensation (15.0) (14.3) (40.3) (38.1)
Depreciation and amortization (95.7) (82.4) (273.4) (241.5)
Loss on disposal or impairment of assets (0.8) (1.9) (3.2) (2.4)
Loss on early extinguishment of debt 0.0 0.0 (3.4) 0.0
Interest expense and amortization of debt discounts and fees (32.2) (30.8) (96.8) (93.0)
Net income attributable to noncontrolling interests 53.7 48.1 160.9 135.9
Change in fair market value of marketable securities (0.3) 1.1 1.9 2.1
Gain on sale of Gamma Knife 0.0 0.0 17.5 0.0
State regulatory change impact on noncontrolling interests 1.5 0.0 1.5 0.0
Income from continuing operations before income tax expense $ 257.8 $ 219.9 $ 808.1 $ 695.3